Related Experiment Video
Updated: Jun 24, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Comparison of Size Determination Using Fenton and World Health Organization Growth Charts in Term Infants
Michaela Wagner1, Katherine A Poehling2, Jordan Yokoyama3
1Pediatrics (M Wagner), Geisinger Health System, Lewistown, Pa; Departments of Pediatrics (M Wagner, KA Poehling, A Elmore, and J Check), Wake Forest University School of Medicine, Winston-Salem, NC.
Insights
Birth weight classification for term infants differs between WHO and Fenton growth charts, impacting postnatal glucose screening protocols. These variations depend on gestational age and infant sex.
Area of Science:
- Neonatalogy
- Pediatric Endocrinology
- Public Health
Background:
- Growth curves for determining infant size at birth vary across U.S. hospitals.
- Accurate size classification is crucial for appropriate neonatal care.
Purpose of the Study:
- To evaluate systematic differences in classifying term infants as small for gestational age (SGA), appropriate for gestational age (AGA), or large for gestational age (LGA) between Fenton and World Health Organization (WHO) growth charts.
- To assess the clinical impact of these classification differences on postnatal glucose screening.
Main Methods:
- Analysis of 10,825 term infants (37-0/7 to 41-6/7 weeks gestational age) born over three years in North Carolina hospitals (rural, suburban, urban).
- Comparison of infant size classifications using Fenton and WHO growth charts.
- Evaluation of implications for postnatal glucose screening based on 2011 American Academy of Pediatrics (AAP) guidelines.
Main Results:
- 71% concordance between Fenton and WHO classifications; 29% discordance.
- Discordance was higher for SGA (Fenton) vs. AGA (WHO) and LGA (WHO) vs. AGA (Fenton).
- Classification differences decreased with advancing gestational age and were more pronounced in male infants. WHO resulted in more SGA/LGA classifications, but potentially shorter glucose screening durations.
Conclusions:
- WHO and Fenton growth charts yield varying birth weight classifications for term infants, influenced by gestational age and sex.
- These discrepancies have clinical implications for neonatal care, specifically affecting postnatal glucose screening durations and protocols.
Objective:
To test the hypothesis that classification as small for gestational age (SGA), appropriate for gestational age (AGA), or large for gestational age (LGA) among term infants would systematically differ between Fenton and World Health Organization (WHO) and that these differences would impact clinical care regarding postnatal glucose screening.
Methods:
All infants born over 3 years (1/1/2020-12/31/2022) between 37-0/7 and 41-6/7-weeks gestational age in one rural, one suburban, or one urban hospital affiliated with an academic medical system in central North Carolina were included.
Results:
Among 10,825 newborns, weight classifications by Fenton and WHO as SGA, AGA, and LGA were concordant for 71%. Among the 29% with discordant classifications, approximately one-third were SGA by Fenton and AGA by WHO, and two-thirds were LGA by WHO and AGA by Fenton. The discordance decreased from 42% at 37-weeks to 6% at 41-weeks gestational age (P < .001). The discordance was higher for male than female newborns (31% vs. 27%, P < .001). The Kappa coefficient increased by gestational age after 38 weeks and was higher for female than male newborns. While more newborns will be classified as either SGA or LGA using WHO than Fenton (32% vs. 25%, P < .001), the minimum duration of postnatal glucose screening using 2011 AAP guidelines is longer for SGA (24 hours) than LGA (12 hours) infants, resulting in a lower cumulative minimum duration with WHO.
Conclusions:
The classification of birth weight by WHO and Fenton growth charts varies across gestational age and sex and has clinical implications regarding postnatal glucose screening.
Related Concept Videos
Drug Dosing: Infants and Children
Nature and Nurture
Regression Toward the Mean
One-Way ANOVA: Unequal Sample Sizes
Teratogenicity
Identifying Statistically Significant Differences: The F-Test

